Top Markets
#1 Islamic Coin Islamic Coin +151.26%
#2 Akedo Akedo +76.66%
#3 Velvet Velvet +52.20%
#4 Glidr Glidr +51.75%
#5 DOVU DOVU +48.24%
#6 Black Phoenix Black Phoenix +33.87%
#7 Cross Cross +32.61%
#8 Cap Cap +20.07%
#9 DoubleZero DoubleZero +16.25%
#10 Movement Movement +9.75%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Evoq Remedies Ltd. Evoq Remedies Ltd.

Evoq Remedies Ltd.

EVOQ
Rank in Stocks #39427
Evoq Remedies Ltd. engages in the provision of pharmaceutical raw materials. It... Evoq Remedies Ltd. engages in the provision of pharmaceutical raw materials. It offers excipients, nutraceuticals, pellets, solvents, sweeteners, vitamins, amino acids, bulk drugs, dairy products, and active pharmaceutical ingredients. The company was founded by Bhumishth Narendrabhai Patel on February 24, 2010 and is headquartered in Ahmedabad, India.
Share Price
$0.0200853
Last synced: 2026-08-13
Market Cap
$500.12K
Change (1 day)
-1.62%
Change (1 year)
-54.13%
Country
IN
Trade Evoq Remedies Ltd. (EVOQ)

Category

Healthcare
P/E ratio for Evoq Remedies Ltd. (EVOQ)
P/E ratio as of 2026 TTM: 0
According to Evoq Remedies Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Evoq Remedies Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 22.16 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 35.07 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 134.86 -
AU
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.